Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5-hydroxytryptamine receptor 5B, pseudogene (HTR5BP) is a non-functional pseudogene in humans that is homologous to the functional 5-HT5B serotonin receptor present in rodents[7][8]. In rodents, the 5-HT5B receptor is a G protein-coupled receptor (GPCR) involved in serotonin signal transduction in the brain, primarily expressed in the habenula, hippocampus, and inferior olive[7]. However, in humans, the HTR5BP gene contains stop codons that prevent the expression of a functional protein, so it does not act as a drug target or have biological activity[7][8][9][3]. The term “receptor” is retained in its historical and orthologous context but does not denote a therapeutic or biological target in humans. **Summary of correct usage:** - HTR5BP is not a functional receptor or a drug target in humans; it is a pseudogene. All references to receptor function or pharmacology apply only to the orthologous, functional gene in rodents[7][8][9].
null for human pseudogene
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-hydroxytryptamine receptor 5B, pseudogene (HTR5BP).